231 related articles for article (PubMed ID: 33648519)
1. High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity.
Liu S; Wang Y; Miao C; Xing Q; Wang Z
Cancer Cell Int; 2021 Mar; 21(1):140. PubMed ID: 33648519
[TBL] [Abstract][Full Text] [Related]
2. Survival Prognosis, Tumor Immune Landscape, and Immune Responses of ADAMTS14 in Clear Cell Renal Cell Carcinoma and Its Potential Mechanisms.
Chen Y; Ji H; Liu S; Xing Q; Zhu B; Wang Y
Front Immunol; 2022; 13():790608. PubMed ID: 35572505
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma.
Wang Y; Cong R; Liu S; Zhu B; Wang X; Xing Q
Cancer Cell Int; 2021 Jan; 21(1):46. PubMed ID: 33430867
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value and immunological role of AXL gene in clear cell renal cell carcinoma associated with identifying LncRNA/RBP/AXL mRNA networks.
Wang Y; Tian Y; Liu S; Wang Z; Xing Q
Cancer Cell Int; 2021 Nov; 21(1):625. PubMed ID: 34838035
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma.
Wang G; Qu F; Liu S; Zhou J; Wang Y
Bioengineered; 2021 Dec; 12(1):4841-4855. PubMed ID: 34334108
[TBL] [Abstract][Full Text] [Related]
6. High Expression of
Wang Y; Zhao Y; Zhang Z; Zhang J; Xu Q; Zhou X; Mao L
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510310
[No Abstract] [Full Text] [Related]
7. Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma.
Wang S; Ma X; Ying Y; Sun J; Yang Z; Li J; Jin K; Wang X; Xie B; Zheng X; Liu B; Xie L
Cancer Cell Int; 2021 Jul; 21(1):341. PubMed ID: 34217271
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma.
Gao Y; Qi JC; Li X; Sun JP; Ji H; Li QH
Oncol Lett; 2020 Jan; 19(1):763-770. PubMed ID: 31897192
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
Fu Y; Sun S; Man X; Kong C
PeerJ; 2019; 7():e7854. PubMed ID: 31592165
[TBL] [Abstract][Full Text] [Related]
10. Systematic Pan-Cancer Analysis of KIF23 and a Prediction Model Based on KIF23 in Clear Cell Renal Cell Carcinoma (ccRCC).
Bai X; Cao Y; Yan X; Tuoheti K; Du G; Chen Z; Wu H; Guo L; Liu T
Pharmgenomics Pers Med; 2021; 14():1717-1729. PubMed ID: 35002290
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Assessment of CDC20 in Patients with Renal Clear Cell Carcinoma and Its Relationship with Body Immunity.
Shi J; Chen Y; Gu X; Wang X; Liu J; Chen X
Contrast Media Mol Imaging; 2022; 2022():7727539. PubMed ID: 35800227
[TBL] [Abstract][Full Text] [Related]
12. Elevated Ras related GTP binding B (RRAGB) expression predicts poor overall survival and constructs a prognostic nomogram for colon adenocarcinoma.
Xiao J; Liu Q; Wu W; Yuan Y; Zhou J; Shi J; Zhou S
Bioengineered; 2021 Dec; 12(1):4620-4632. PubMed ID: 34320917
[TBL] [Abstract][Full Text] [Related]
13. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma.
Zhang Y; Hua X; Shi H; Zhang L; Xiao H; Liang C
Cancer Cell Int; 2021 Dec; 21(1):680. PubMed ID: 34923969
[TBL] [Abstract][Full Text] [Related]
14. Survival Prognosis, Tumor Immune Landscape, and Immune Responses of PPP1R18 in Kidney Renal Clear Cell Carcinoma and Its Potentially Double Mechanisms.
Wang Y; Liu S; Chen Y; Zhu B; Xing Q
World J Oncol; 2022 Feb; 13(1):27-37. PubMed ID: 35317332
[TBL] [Abstract][Full Text] [Related]
15. Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Yicong Y; Wang Y; Denglong W; Baoying H
Front Oncol; 2021; 11():666418. PubMed ID: 34136398
[TBL] [Abstract][Full Text] [Related]
16. Elevated THBS3 predicts poor overall survival for clear cell renal cell carcinoma and identifies LncRNA/RBP/THBS3 mRNA networks.
Wang G; Qu F; Zhou J; Zhu B; Gao Y
Cell Cycle; 2023 Feb; 22(3):316-330. PubMed ID: 36045611
[TBL] [Abstract][Full Text] [Related]
17. The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma.
Zhou Y; Wang X; Zhang W; Liu H; Liu D; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
Front Oncol; 2021; 11():630706. PubMed ID: 33968730
[TBL] [Abstract][Full Text] [Related]
18. Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment.
Wei X; Wang Y; Ji C; Luan J; Yao L; Zhang X; Wang S; Yao B; Qin C; Song N
Front Genet; 2021; 12():706661. PubMed ID: 34712264
[No Abstract] [Full Text] [Related]
19.
Al Sharie AH; Al Zu'bi YO; El-Elimat T; Al-Kammash K; Abu Lil A; Isawi IH; Al Sharie S; Abu Mousa BM; Al Malkawi AA; Alali FQ
J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836529
[No Abstract] [Full Text] [Related]
20. Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing.
Zhang X; Zhou J; Wang Y; Wang X; Zhu B; Xing Q
Biochem Genet; 2023 Aug; ():. PubMed ID: 37642814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]